Return On Assets of Avalo Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Avalo Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Avalo Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -74%, a 716% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2024 was -29%, a 74% increase from 2023.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2023 was -114%, a 12% decline from 2022.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2022 was -102%, a 8.8% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Avalo Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -74% -65% -716% 01 Jul 2025 30 Sep 2025
Q2 2025 -36% +15% +30% 01 Apr 2025 30 Jun 2025
Q1 2025 59% +347% 01 Jan 2025 31 Mar 2025
Q4 2024 -29% +85% +74% 01 Oct 2024 31 Dec 2024
Q3 2024 -9.1% +99% +92% 01 Jul 2024 30 Sep 2024
Q2 2024 -51% +25% +32% 01 Apr 2024 30 Jun 2024
Q1 2024 -288% -203% -237% 01 Jan 2024 31 Mar 2024
Q4 2023 -114% -12% -12% 01 Oct 2023 31 Dec 2023
Q3 2023 -108% -11% -11% 01 Jul 2023 30 Sep 2023
Q2 2023 -76% +30% +28% 01 Apr 2023 30 Jun 2023
Q1 2023 -85% +15% +15% 01 Jan 2023 31 Mar 2023
Q4 2022 -102% +9.8% +8.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -97% +24% +20% 01 Jul 2022 30 Sep 2022
Q2 2022 -106% +27% +20% 01 Apr 2022 30 Jun 2022
Q1 2022 -100% +24% +19% 01 Jan 2022 31 Mar 2022
Q4 2021 -111% +6.1% +5.2% 01 Oct 2021 31 Dec 2021
Q3 2021 -121% -33% -37% 01 Jul 2021 30 Sep 2021
Q2 2021 -134% -62% -87% 01 Apr 2021 30 Jun 2021
Q1 2021 -124% -64% -106% 01 Jan 2021 31 Mar 2021
Q4 2020 -117% -89% -316% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -53% -150% 01 Jul 2020 30 Sep 2020
Q2 2020 -71% -6.8% -11% 01 Apr 2020 30 Jun 2020
Q1 2020 -60% +3.1% +4.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -28% +32% +53% 01 Oct 2019 31 Dec 2019
Q3 2019 -36% +28% +44% 01 Jul 2019 30 Sep 2019
Q2 2019 -64% -76% -657% 01 Apr 2019 30 Jun 2019
Q1 2019 -63% -91% -327% 01 Jan 2019 31 Mar 2019
Q4 2018 -60% -119% -203% 01 Oct 2018 31 Dec 2018
Q3 2018 -63% -185% -152% 01 Jul 2018 30 Sep 2018
Q2 2018 12% +197% 01 Apr 2018 30 Jun 2018
Q1 2018 28% +194% 01 Jan 2018 31 Mar 2018
Q4 2017 59% +204% 01 Oct 2017 31 Dec 2017
Q3 2017 122% +243% 01 Jul 2017 30 Sep 2017
Q2 2017 -185% -94% -104% 01 Apr 2017 30 Jun 2017
Q1 2017 -166% 01 Jan 2017 31 Mar 2017
Q4 2016 -145% 01 Oct 2016 31 Dec 2016
Q3 2016 -121% 01 Jul 2016 30 Sep 2016
Q2 2016 -91% 01 Apr 2016 30 Jun 2016

Avalo Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -29% +85% +74% 01 Jan 2024 31 Dec 2024
2023 -114% -12% -12% 01 Jan 2023 31 Dec 2023
2022 -102% +9.8% +8.8% 01 Jan 2022 31 Dec 2022
2021 -111% +6.1% +5.2% 01 Jan 2021 31 Dec 2021
2020 -117% -89% -316% 01 Jan 2020 31 Dec 2020
2019 -28% +32% +53% 01 Jan 2019 31 Dec 2019
2018 -60% -119% -203% 01 Jan 2018 31 Dec 2018
2017 59% +204% 01 Jan 2017 31 Dec 2017
2016 -145% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.